https://www.bloomberg.com/authors/APARuU4pCz4/margaret-tirrell RSS for Node Thu, 07 May 2026 18:25:28 GMT https://www.bloomberg.com/news/articles/2014-03-12/geron-plummets-as-fda-halts-development-of-blood-disorder-drug https://www.bloomberg.com/news/articles/2014-03-12/geron-plummets-as-fda-halts-development-of-blood-disorder-drug Wed, 12 Mar 2014 20:13:22 GMT https://www.bloomberg.com/news/articles/2014-03-07/sanofi-regeneron-must-assess-risk-in-new-cholesterol-drug https://www.bloomberg.com/news/articles/2014-03-07/sanofi-regeneron-must-assess-risk-in-new-cholesterol-drug Fri, 07 Mar 2014 22:30:12 GMT https://www.bloomberg.com/news/articles/2014-03-06/sangamo-rises-to-highest-value-in-13-years-on-hiv-treatment-data https://www.bloomberg.com/news/articles/2014-03-06/sangamo-rises-to-highest-value-in-13-years-on-hiv-treatment-data Thu, 06 Mar 2014 21:04:49 GMT https://www.bloomberg.com/news/articles/2014-02-26/illumina-dna-screen-for-down-syndrome-found-more-accurate https://www.bloomberg.com/news/articles/2014-02-26/illumina-dna-screen-for-down-syndrome-found-more-accurate Thu, 27 Feb 2014 21:09:08 GMT https://www.bloomberg.com/news/articles/2014-02-25/intermune-soars-on-lung-study-likely-to-support-u-s-approval https://www.bloomberg.com/news/articles/2014-02-25/intermune-soars-on-lung-study-likely-to-support-u-s-approval Tue, 25 Feb 2014 21:17:29 GMT https://www.bloomberg.com/news/articles/2014-02-21/ariad-adds-activist-investor-alex-denner-of-sarissa-to-board https://www.bloomberg.com/news/articles/2014-02-21/ariad-adds-activist-investor-alex-denner-of-sarissa-to-board Fri, 21 Feb 2014 21:07:14 GMT https://www.bloomberg.com/news/articles/2014-02-20/incyte-may-be-undervalued-even-after-tripling-new-chief-says https://www.bloomberg.com/news/articles/2014-02-20/incyte-may-be-undervalued-even-after-tripling-new-chief-says Fri, 21 Feb 2014 21:05:19 GMT https://www.bloomberg.com/news/articles/2014-02-21/fda-issues-first-order-to-stop-sale-of-tobacco-products https://www.bloomberg.com/news/articles/2014-02-21/fda-issues-first-order-to-stop-sale-of-tobacco-products Fri, 21 Feb 2014 18:21:28 GMT https://www.bloomberg.com/news/articles/2014-02-20/jpmorgan-dad-starts-biotech-in-muscular-dystrophy-quest https://www.bloomberg.com/news/articles/2014-02-20/jpmorgan-dad-starts-biotech-in-muscular-dystrophy-quest Thu, 20 Feb 2014 05:01:00 GMT https://www.bloomberg.com/news/articles/2014-02-15/biogen-names-papadopoulos-as-its-chairman-replacing-young https://www.bloomberg.com/news/articles/2014-02-15/biogen-names-papadopoulos-as-its-chairman-replacing-young Sat, 15 Feb 2014 19:49:10 GMT https://www.bloomberg.com/news/articles/2014-02-15/biogen-said-to-name-papadopoulos-as-new-chairman https://www.bloomberg.com/news/articles/2014-02-15/biogen-said-to-name-papadopoulos-as-new-chairman Sat, 15 Feb 2014 13:18:23 GMT https://www.bloomberg.com/news/articles/2014-02-12/gilead-s-milligan-says-hepatitis-c-drug-attracts-payers https://www.bloomberg.com/news/articles/2014-02-12/gilead-s-milligan-says-hepatitis-c-drug-attracts-payers Wed, 12 Feb 2014 21:06:17 GMT https://www.bloomberg.com/news/articles/2014-02-04/gilead-profit-tops-estimates-on-hepatitis-c-drug-sales https://www.bloomberg.com/news/articles/2014-02-04/gilead-profit-tops-estimates-on-hepatitis-c-drug-sales Wed, 05 Feb 2014 21:04:18 GMT https://www.bloomberg.com/news/articles/2014-01-30/amgen-readies-cholesterol-drug-after-results-from-trial https://www.bloomberg.com/news/articles/2014-01-30/amgen-readies-cholesterol-drug-after-results-from-trial Fri, 31 Jan 2014 21:13:17 GMT https://www.bloomberg.com/news/articles/2014-01-31/intermune-sinks-on-competition-from-boehringer-lung-drug https://www.bloomberg.com/news/articles/2014-01-31/intermune-sinks-on-competition-from-boehringer-lung-drug Fri, 31 Jan 2014 21:09:52 GMT https://www.bloomberg.com/news/articles/2014-01-30/alexion-jumps-as-lower-than-projected-tax-rate-boosts-profit https://www.bloomberg.com/news/articles/2014-01-30/alexion-jumps-as-lower-than-projected-tax-rate-boosts-profit Thu, 30 Jan 2014 21:39:20 GMT https://www.bloomberg.com/news/articles/2014-01-29/biogen-fourth-quarter-profit-rises-on-multiple-sclerosis-drugs https://www.bloomberg.com/news/articles/2014-01-29/biogen-fourth-quarter-profit-rises-on-multiple-sclerosis-drugs Wed, 29 Jan 2014 21:19:06 GMT https://www.bloomberg.com/news/articles/2014-01-28/amgen-fourth-quarter-earnings-rise-on-higher-drug-sales https://www.bloomberg.com/news/articles/2014-01-28/amgen-fourth-quarter-earnings-rise-on-higher-drug-sales Tue, 28 Jan 2014 21:19:31 GMT https://www.bloomberg.com/news/articles/2014-01-24/ariad-gains-as-investors-bet-on-takeover-interest https://www.bloomberg.com/news/articles/2014-01-24/ariad-gains-as-investors-bet-on-takeover-interest Fri, 24 Jan 2014 21:12:03 GMT https://www.bloomberg.com/news/articles/2014-01-23/baxter-predicts-2014-earnings-that-surpass-estimates-on-dialysis https://www.bloomberg.com/news/articles/2014-01-23/baxter-predicts-2014-earnings-that-surpass-estimates-on-dialysis Thu, 23 Jan 2014 21:08:50 GMT